Funded Tech Companies
Amygdala Neurosciences
Wondering who provided funding to Amygdala Neurosciences? Private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Amygdala Neurosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
509 Hale St.
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Amygdala Neurosciences is developing ANS-6637 for the treatment of substance use disorder. NIH funded Phase-2 studies for opioid and alcohol use disorders will begin in 2019. We are also planning to start a Phase-2 study for smoking cessation and studies to support cocaine use disorder development in 2019.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/19/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Lou Lange
Chief Executive Officer
Peter Strumph
Chief Financial Officer
Adrienne MacMillan
Chief Medical Officer
Mack Mitchell
Chief Scientific Officer
Ivan Diamond
VP - Bus. Development
Brent Blackburn
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs